News & Media
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BillionToOne closes its follow-on Series A+ funding round of $15 million
BillionToOne closes its follow-on Series A+ funding round of $15 million
BillionToOne to present series of single-gene NIPT posters at 2020 ACMG Annual Clinical Genetics Meeting
BillionToOne to present series of single-gene NIPT posters at 2020 ACMG Annual Clinical Genetics Meeting
BillionToOne to present a novel method to quantify the abundance of nucleic acid species at 20th AGBT Conference
BillionToOne to present a novel method to quantify the abundance of nucleic acid species at 20th AGBT Conference
BillionToOne to present single-gene NIPT poster at 40th SMFM conference
BillionToOne to present single-gene NIPT poster at 40th SMFM conference
A Conversation with Dr. Oguzhan Atay, CEO BillionToOne, Inc
A Conversation with Dr. Oguzhan Atay, CEO BillionToOne, Inc
Prenatal Blood Test for SMA Now Available in Four Countries in Europe, BillionToOne Announces
Prenatal Blood Test for SMA Now Available in Four Countries in Europe, BillionToOne Announces
BillionToOne, Inc. and Eluthia Launch UNITY™ Test, the First Non-Invasive Prenatal Test for Cystic Fibrosis, Spinal Muscular Atrophy and Hemoglobinopathies in Germany, Austria, Switzerland and the Netherlands
BillionToOne, Inc. and Eluthia Launch UNITY™ Test, the First Non-Invasive Prenatal Test for Cystic Fibrosis, Spinal Muscular Atrophy and Hemoglobinopathies in Germany, Austria, Switzerland and the Netherlands
Social Posts